Cargando…

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure

Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for heart failure (HF). Although some progress has been made in improving survival among patients admitted for HF, the rates of hospital readmissions and the related costs continue to rise dramatically. We sought to examine whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valbusa, Filippo, Bonapace, Stefano, Agnoletti, Davide, Scala, Luca, Grillo, Cristina, Arduini, Pietro, Turcato, Emanuela, Mantovani, Alessandro, Zoppini, Giacomo, Arcaro, Guido, Byrne, Christopher, Targher, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348001/ https://www.ncbi.nlm.nih.gov/pubmed/28288193 http://dx.doi.org/10.1371/journal.pone.0173398

Ejemplares similares

Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
por: Valbusa, Filippo, et al.
Publicado: (2016)

Controlling nutritional status score predicts 2-year outcomes in elderly patients admitted for acute heart failure
por: Agnoletti, Davide, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2015)

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
por: Mantovani, Alessandro, et al.
Publicado: (2017)

Increased Pulse Pressure Independently Predicts Incident Atrial Fibrillation in Patients With Type 2 Diabetes
por: Valbusa, Filippo, et al.
Publicado: (2012)

Increased aortic stiffness in adults with chronic indeterminate Chagas disease
por: Valbusa, Filippo, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
por: Bonapace, Stefano, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
por: Bonapace, Stefano, et al.
Publicado: (2014)

Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Rossi, Andrea, et al.
Publicado: (2012)

Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2012)

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2018)

The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2016)

The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies
por: Zoppini, Giacomo, et al.
Publicado: (2018)

Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
por: Targher, Giovanni
Publicado: (2020)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2009)

High-Normal HbA(1c) Is a Strong Predictor of Type 2 Diabetes in the General Population
por: Bonora, Enzo, et al.
Publicado: (2011)

Sensitivity and Specificity of Transthoracic Echocardiography in Diagnosing the Presence of the Anomalous Origin of Left Circumflex Coronary Artery From the Right Sinus of Valsalva in an Adult Population
por: Bonapace, Stefano, et al.
Publicado: (2023)

Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
por: Zoppini, Giacomo, et al.
Publicado: (2012)

Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease – a growing public health problem
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Glycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2013)

Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial
por: Targher, Giovanni, et al.
Publicado: (2020)

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis
por: Ata, Fateen, et al.
Publicado: (2023)

Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

All-Cause Readmission or Potentially Avoidable Readmission: Which Is More Predictable Using Frailty, Comorbidities, and ADL?
por: Mitsutake, Seigo, et al.
Publicado: (2023)

Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients
por: Jiang, Ting-Ting, et al.
Publicado: (2021)

Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis
por: Zhang, Rui, et al.
Publicado: (2022)

An observational study of nurse staffing ratios and hospital readmission among children admitted for common conditions
por: Tubbs-Cooley, Heather L, et al.
Publicado: (2013)

Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation
por: Zaccardi, Francesco, et al.
Publicado: (2017)

Lower levels of 25-hydroxyvitamin D(3) are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2015)

The impact of COVID-19 pandemic on the urgency of patients admitted to the emergency department
por: Zaboli, Arian, et al.
Publicado: (2022)

acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study
por: Wu, Xi-Xi, et al.
Publicado: (2021)

Australian Injury Comorbidity Indices (AICIs) to predict burden and readmission among hospital-admitted injury patients
por: Fernando, Dasamal Tharanga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lr9jrrbdu117dpaj05uemtb2ea